{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:32:27Z","timestamp":1793291547788,"version":"4.5.0"},"reference-count":144,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1111\/all.13083","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T13:46:45Z","timestamp":1479304005000},"page":"519-533","source":"Crossref","is-referenced-by-count":265,"title":["Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria"],"prefix":"10.1111","volume":"72","author":[{"given":"A. P.","family":"Kaplan","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology; Department of Medicine; Medical University of South Carolina; Charleston SC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Gim\u00e9nez-Arnau","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital del Mar, Institut Mar D'Investigacions Mediques; Universitat Aut\u00f2noma; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Saini","sequence":"additional","affiliation":[{"name":"Johns Hopkins Asthma and Allergy Center; Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"key":"10.1111\/all.13083-BIB0001|all13083-cit-0001","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0002|all13083-cit-0002","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA(2) LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0003|all13083-cit-0003","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","article-title":"Chronic urticaria: pathogenesis and treatment","volume":"114","author":"Kaplan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0004|all13083-cit-0004","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0091-6749(84)90451-2","article-title":"Late cutaneous reactions in patients with delayed pressure urticaria","volume":"73","author":"Davis","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0005|all13083-cit-0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0091-6749(88)90982-7","article-title":"Isolated late cutaneous skin test response to ampicillin: a distinct entity","volume":"82","author":"Dolovich","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0006|all13083-cit-0006","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archderm.1988.01670020048016","article-title":"Delayed pressure urticaria histologically resembles cutaneous late-phase reactions","volume":"124","author":"Mekori","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1111\/all.13083-BIB0007|all13083-cit-0007","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mai.2002.123236","article-title":"TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction","volume":"109","author":"Ying","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0008|all13083-cit-0008","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1172\/JCI108485","article-title":"The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies","volume":"58","author":"Solley","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1111\/all.13083-BIB0009|all13083-cit-0009","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0010|all13083-cit-0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40257-015-0134-8","article-title":"Resource use and costs in an insured population of patients with chronic idiopathic\/spontaneous urticaria","volume":"16","author":"Broder","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/all.13083-BIB0011|all13083-cit-0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.iac.2013.09.012","article-title":"Chronic spontaneous urticaria: etiology and pathogenesis","volume":"34","author":"Saini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1111\/all.13083-BIB0012|all13083-cit-0012","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1398-9995.2011.02570.x","article-title":"Basophil recruitment and activation in inflammatory skin diseases","volume":"66","author":"Ito","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0013|all13083-cit-0013","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0091-6749(99)70475-6","article-title":"Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-Fc\u03b5RI or anti-IgE autoantibodies","volume":"103","author":"Sabroe","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0014|all13083-cit-0014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0091-6749(83)90096-9","article-title":"Histologic studies of chronic idiopathic urticaria","volume":"71","author":"Natbony","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0015|all13083-cit-0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0091-6749(86)90033-3","article-title":"Prostaglandin D2 and histamine release in cold urticaria","volume":"78","author":"Heavey","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0016|all13083-cit-0016","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","article-title":"Comparative studies of functional and binding assays for IgG anti-Fc\u03b5RI\u03b1 (alpha-subunit) in chronic urticaria","volume":"101","author":"Ferrer","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0017|all13083-cit-0017","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2009.03256.x","article-title":"Pathogenesis of chronic urticaria","volume":"39","author":"Kaplan","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13083-BIB0018|all13083-cit-0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/1523-1747.ep12471120","article-title":"The effect of prostaglandin D2 on the response of human skin to histamine","volume":"89","author":"Maurice","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0019|all13083-cit-0019","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0091-6749(88)90968-2","article-title":"Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation","volume":"82","author":"Ormerod","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0020|all13083-cit-0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002280000249","article-title":"Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2","volume":"57","author":"Saarinen","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/all.13083-BIB0021|all13083-cit-0021","first-page":"s73","article-title":"Gene expression profiling in chronic spontaneous urticaria","volume":"134","author":"Curto-Barredo","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0022|all13083-cit-0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2500\/ar.2015.6.0124","article-title":"Gene expression profiles in chronic idiopathic (spontaneous) urticaria","volume":"6","author":"Patel","year":"2015","journal-title":"Allergy Rhinol"},{"key":"10.1111\/all.13083-BIB0023|all13083-cit-0023","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.anai.2014.03.016","article-title":"Increased epidermal filaggrin in chronic idiopathic urticaria is associated with severity of urticaria","volume":"112","author":"Ye","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/all.13083-BIB0024|all13083-cit-0024","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4049\/jimmunol.1300290","article-title":"Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation","volume":"192","author":"Morimoto","year":"2014","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0025|all13083-cit-0025","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/cea.12509","article-title":"Differential TLR-induced cytokine production by human mast cells is amplified by Fcvar\u03b5RI triggering","volume":"45","author":"Suurmond","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13083-BIB0026|all13083-cit-0026","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.coi.2008.09.005","article-title":"New concepts in chronic urticaria","volume":"20","author":"Vonakis","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/all.13083-BIB0027|all13083-cit-0027","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clim.2009.05.003","article-title":"Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2","volume":"132","author":"Saini","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1111\/all.13083-BIB0028|all13083-cit-0028","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","article-title":"Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria","volume":"328","author":"Hide","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/all.13083-BIB0029|all13083-cit-0029","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1398-9995.2011.02704.x","article-title":"Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation","volume":"66","author":"Bossi","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0030|all13083-cit-0030","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jaci.2006.04.015","article-title":"Molecular regulation of mast cell activation","volume":"117","author":"Rivera","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0031|all13083-cit-0031","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACI.0000000000000083","article-title":"Biologic agents and the therapy of chronic spontaneous urticaria","volume":"14","author":"Kaplan","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0032|all13083-cit-0032","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2014.04.036","article-title":"The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria","volume":"135","author":"Chang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0033|all13083-cit-0033","unstructured":"Xolair\u00ae (omalizumab) US prescribing information 2016. Available from: https:\/\/www.gene.com\/download\/pdf\/xolair_prescribing.pdf 2014"},{"key":"10.1111\/all.13083-BIB0034|all13083-cit-0034","unstructured":"European Medicines Agency Xolair: European public assessment report - Product Information Summary of product characteristics 2015 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000606\/WC500057298.pdf"},{"key":"10.1111\/all.13083-BIB0035|all13083-cit-0035","first-page":"415","article-title":"Pharmaceutical approval update","volume":"39","author":"Goldenberg","year":"2014","journal-title":"P T"},{"key":"10.1111\/all.13083-BIB0036|all13083-cit-0036","unstructured":"European Medicines Agency Xolair-H-C-606-II-48: EPAR - Assessment Report - Variation 2014 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000606\/WC500164453.pdf"},{"key":"10.1111\/all.13083-BIB0037|all13083-cit-0037","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","article-title":"Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy","volume":"132","author":"Kaplan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0038|all13083-cit-0038","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/all.13083-BIB0039|all13083-cit-0039","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2014.306","article-title":"Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on h1 antihistamines: a randomized, placebo-controlled study","volume":"135","author":"Saini","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0040|all13083-cit-0040","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of Fc\u03b5RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"MacGlashan","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0041|all13083-cit-0041","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.4049\/jimmunol.162.9.5624","article-title":"Down-regulation of human basophil IgE and FC\u03b5RI\u03b1 surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo","volume":"162","author":"Saini","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0042|all13083-cit-0042","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0043|all13083-cit-0043","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab-induced reductions in mast cell Fce psilon RI expression and function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0044|all13083-cit-0044","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.151.5.2623","article-title":"Humanization of an antibody directed against IgE","volume":"151","author":"Presta","year":"1993","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0045|all13083-cit-0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000237010","article-title":"Inhibition of allergic reactions with antibodies to IgE","volume":"107","author":"Shields","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.13083-BIB0046|all13083-cit-0046","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2009.10.021","article-title":"Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0047|all13083-cit-0047","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.70.2.207","article-title":"IgE-regulated loss, not IgE-regulated synthesis, controls expression of Fc\u03b5RI in human basophils","volume":"70","author":"MacGlashan","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1111\/all.13083-BIB0048|all13083-cit-0048","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell Fc\u03b5RI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0049|all13083-cit-0049","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaci.2013.04.056","article-title":"Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation","volume":"132","author":"Macglashan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0050|all13083-cit-0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/cea.12400","article-title":"Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects","volume":"44","author":"Arm","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13083-BIB0051|all13083-cit-0051","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2009.09.012","article-title":"Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge","volume":"125","author":"Eckman","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0052|all13083-cit-0052","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2012.05.039","article-title":"Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy","volume":"130","author":"Savage","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0053|all13083-cit-0053","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/jid.2013.541","article-title":"Differences in effects of omalizumab on late-phase responses to allergen challenge in the skin and nose at the time of basophil hyporesponsiveness","volume":"134","author":"Paterniti","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0054|all13083-cit-0054","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaci.2005.05.035","article-title":"Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge","volume":"116","author":"Ong","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0055|all13083-cit-0055","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jaci.2007.12.1121","article-title":"Effect of anti-IgE (Omalizumab) in Chronic Idiopathic Urticaria (CIU) patients","volume":"121","author":"Gober","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0056|all13083-cit-0056","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","article-title":"Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase","volume":"128","author":"Maurer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0057|all13083-cit-0057","first-page":"S30","article-title":"Omalizumab normalizes levels of high affinity immunoglobulin E receptor-positive skin cells in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study","volume":"134","author":"Metz","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0058|all13083-cit-0058","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2013.08.011","article-title":"Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis","volume":"73","author":"Metz","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1111\/all.13083-BIB0059|all13083-cit-0059","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4049\/jimmunol.146.2.671","article-title":"Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen","volume":"146","author":"Charlesworth","year":"1991","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0060|all13083-cit-0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0061|all13083-cit-0061","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1398-9995.1962.tb02937.x","article-title":"Basophilic leucopenia in different forms of urticaria","volume":"17","author":"Rorsman","year":"1962","journal-title":"Acta Allergol"},{"key":"10.1111\/all.13083-BIB0062|all13083-cit-0062","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI108405","article-title":"Defective histamine release in chronic urticaria","volume":"57","author":"Kern","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1111\/all.13083-BIB0063|all13083-cit-0063","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2222.1974.tb01384.x","article-title":"Serum and cell bound IgE in chronic urticaria","volume":"4","author":"Greaves","year":"1974","journal-title":"Clin Allergy"},{"key":"10.1111\/all.13083-BIB0064|all13083-cit-0064","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/jid.2008.55","article-title":"Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies","volume":"128","author":"Eckman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0065|all13083-cit-0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/all.12578","article-title":"Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria","volume":"70","author":"Oliver","year":"2015","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0066|all13083-cit-0066","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60644-8","article-title":"Effect of omalizumab on patients with chronic urticaria","volume":"99","author":"Spector","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/all.13083-BIB0067|all13083-cit-0067","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000250436","article-title":"Reduced Fc\u03b5RI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy","volume":"151","author":"Oliver","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.13083-BIB0068|all13083-cit-0068","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4049\/jimmunol.167.3.1290","article-title":"Minimal requirements for IgE-mediated regulation of surface Fc\u03b5RI","volume":"167","author":"Borkowski","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0069|all13083-cit-0069","unstructured":"Metz M Staubach P Bauer A Brehler R Gericke J Kangas M Omalizumab normalizes levels of high affinity IgE receptor-positive skin cells in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study Copenhagen, Denmark 2014"},{"key":"10.1111\/all.13083-BIB0070|all13083-cit-0070","unstructured":"Metz MTR Letzkus M Hartmann N Staubach P Bauer A Brehler R Omalizumab normalizes gene expression in lesional skin of patients with chronic spontaneous urticaria: results from a randomized, double-blind, placebo-controlled study European Academy of Dermatology and Venereology 2015"},{"key":"10.1111\/all.13083-BIB0071|all13083-cit-0071","unstructured":"Novartis Data on File"},{"key":"10.1111\/all.13083-BIB0072|all13083-cit-0072","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jaci.2010.12.1085","article-title":"Omalizumab is effective in nonautoimmune urticaria","volume":"127","author":"Ferrer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0073|all13083-cit-0073","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.179.2.1353","article-title":"Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc\u03b5RI on human skin mast cells","volume":"179","author":"Gomez","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0074|all13083-cit-0074","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2015.08.023","article-title":"Timing and duration of omalizumab response in patients with chronic idiopathic\/spontaneous urticaria","volume":"137","author":"Kaplan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0075|all13083-cit-0075","doi-asserted-by":"crossref","first-page":"AB127","DOI":"10.1016\/j.jaci.2014.12.1347","article-title":"Response patterns in chronic idiopathic\/spontaneous urticaria (CIU\/CSU) patients treated with omalizumab for 24 weeks in two randomized, double-blind, placebo-controlled clinical trials (ASTERIA I and GLACIAL)","volume":"135","author":"Kaplan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0076|all13083-cit-0076","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2006.04.005","article-title":"Anti-IgE as a mast cell-stabilizing therapeutic agent","volume":"117","author":"Chang","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0077|all13083-cit-0077","first-page":"843","article-title":"Differences in irradiation susceptibility and turnover between mucosal and connective tissue-type mast cells of mice","volume":"18","author":"Fukuzumi","year":"1990","journal-title":"Exp Hematol"},{"key":"10.1111\/all.13083-BIB0078|all13083-cit-0078","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.155.6.3152","article-title":"Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88\/C5aR expression on skin mast cells","volume":"155","author":"Fureder","year":"1995","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0079|all13083-cit-0079","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02126554","article-title":"Allergy or inflammation? From neuropeptide stimulation of human skin mast cells to studies on the mechanism of the late asthmatic response","volume":"26","author":"Church","year":"1989","journal-title":"Agents Actions"},{"key":"10.1111\/all.13083-BIB0080|all13083-cit-0080","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0091-6749(92)90297-F","article-title":"Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission","volume":"89","author":"Jacques","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0081|all13083-cit-0081","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0091-6749(86)90260-5","article-title":"Increased compound 48\/80 induced local histamine release from nonlesional skin of patients with chronic urticaria","volume":"78","author":"Bedard","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0082|all13083-cit-0082","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0091-6749(05)80184-8","article-title":"Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria","volume":"86","author":"Brunet","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0083|all13083-cit-0083","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2006.08.177","article-title":"Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors","volume":"349","author":"Tatemoto","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/all.13083-BIB0084|all13083-cit-0084","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0085|all13083-cit-0085","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jaci.2004.07.064","article-title":"Loss of receptors and IgE in vivo during treatment with anti-IgE antibody","volume":"114","author":"MacGlashan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0086|all13083-cit-0086","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaci.2007.03.032","article-title":"Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis","volume":"119","author":"Carter","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0087|all13083-cit-0087","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2169\/internalmedicine.50.4640","article-title":"Omalizumab treatment of systemic mast cell activation disease: experiences from four cases","volume":"50","author":"Molderings","year":"2011","journal-title":"Intern Med"},{"key":"10.1111\/all.13083-BIB0088|all13083-cit-0088","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2222.2003.01589.x","article-title":"Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity","volume":"33","author":"Grattan","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13083-BIB0089|all13083-cit-0089","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.1997.tb02986.x","article-title":"Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity","volume":"27","author":"Grattan","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13083-BIB0090|all13083-cit-0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-6749(98)70283-0","article-title":"Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria","volume":"102","author":"Sabroe","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0091|all13083-cit-0091","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/S0091-6749(03)80602-4","article-title":"Signaling defects in basophils in chronic urticaria","volume":"111","author":"Saini","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0092|all13083-cit-0092","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2500\/aap.2011.32.3483","article-title":"Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria","volume":"32","author":"Magen","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1111\/all.13083-BIB0093|all13083-cit-0093","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.10.007","article-title":"Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals","volume":"114","author":"Caproni","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1111\/all.13083-BIB0094|all13083-cit-0094","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.12991","article-title":"Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin","volume":"171","author":"Kay","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/all.13083-BIB0095|all13083-cit-0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11882-009-0040-3","article-title":"Basophil responsiveness in chronic urticaria","volume":"9","author":"Saini","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/all.13083-BIB0096|all13083-cit-0096","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaci.2015.06.004","article-title":"Altered expression of chemoattractant receptor-homologous molecule expressed on T(H)2 cells on blood basophils and eosinophils in patients with chronic spontaneous urticaria","volume":"137","author":"Oliver","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0097|all13083-cit-0097","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2012.05.038","article-title":"Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors","volume":"130","author":"MacGlashan","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0098|all13083-cit-0098","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jaci.2009.12.996","article-title":"Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab","volume":"125","author":"Zaidi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0099|all13083-cit-0099","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2006.09.035","article-title":"Basophil Fc\u03b5RI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria","volume":"119","author":"Vonakis","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0100|all13083-cit-0100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2222.2005.02212.x","article-title":"Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli","volume":"35","author":"Luquin","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13083-BIB0101|all13083-cit-0101","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/jid.2015.13","article-title":"Suppression of basophil Fcvar\u03b5RI activation by serum from active chronic idiopathic\/spontaneous urticaria (CIU\/CSU) subjects","volume":"135","author":"Sterba","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0102|all13083-cit-0102","doi-asserted-by":"crossref","first-page":"AB117","DOI":"10.1016\/j.jaci.2013.12.434","article-title":"Whole blood histamine concentration response to omalizumab in patients with chronic idiopathic\/spontaneous urticaria: post hoc analysis of ASTERIA I, ASTERIA II and GLACIAL studies","volume":"133","author":"Saini","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0103|all13083-cit-0103","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1523-1747.ep12338544","article-title":"Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria","volume":"106","author":"Niimi","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0104|all13083-cit-0104","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1067\/mai.2001.115484","article-title":"Mechanisms of autoimmune activation of basophils in chronic urticaria","volume":"107","author":"Kikuchi","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0105|all13083-cit-0105","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI118325","article-title":"Serum IgG autoantibodies directed against the alpha chain of Fc\u03b5RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?","volume":"96","author":"Fiebiger","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/all.13083-BIB0106|all13083-cit-0106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0091-6749(97)70071-X","article-title":"Assessment of autoimmunity in patients with chronic urticaria","volume":"99","author":"Tong","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0107|all13083-cit-0107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","article-title":"Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes","volume":"90","author":"Gruber","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0108|all13083-cit-0108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/all.12056","article-title":"EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria","volume":"68","author":"Konstantinou","year":"2013","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0109|all13083-cit-0109","doi-asserted-by":"crossref","first-page":"e14794","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase - a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/all.13083-BIB0110|all13083-cit-0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anai.2012.10.020","article-title":"Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders","volume":"110","author":"Cho","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/all.13083-BIB0111|all13083-cit-0111","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jaci.2014.06.029","article-title":"\u201cAuto-anti-IgE\u201d: naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation","volume":"134","author":"Chan","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0112|all13083-cit-0112","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/jid.2008.416","article-title":"Independent evaluation of a commercial test for \u201cautoimmune\u201d urticaria in normal and chronic urticaria subjects","volume":"129","author":"Eckman","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0113|all13083-cit-0113","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2006.10.002","article-title":"Antinuclear antibodies in the oldest-old women and men","volume":"27","author":"Nilsson","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1111\/all.13083-BIB0114|all13083-cit-0114","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/rheumatology\/32.7.546","article-title":"The relation between class-specific serum rheumatoid factors and age in the general population","volume":"32","author":"Schaardenburg","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1111\/all.13083-BIB0115|all13083-cit-0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1191\/0961203303lu1015oa","article-title":"Predictive value of autoantibodies for activity of systemic lupus erythematosus","volume":"13","author":"Reveille","year":"2004","journal-title":"Lupus"},{"key":"10.1111\/all.13083-BIB0116|all13083-cit-0116","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-Fc\u03b5RI\u03b1 autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/all.13083-BIB0117|all13083-cit-0117","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2007.05.008","article-title":"Basophil secretion in chronic urticaria: autoantibody-dependent or not?","volume":"120","author":"Kaplan","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0118|all13083-cit-0118","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2012.01.043","article-title":"Chronic urticaria and autoimmunity: associations found in a large population study","volume":"129","author":"Confino-Cohen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0119|all13083-cit-0119","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.aller.2014.02.007","article-title":"Hashimoto's disease is a frequent comorbidity and an exacerbating factor of chronic spontaneous urticaria","volume":"43","author":"Sugiyama","year":"2015","journal-title":"Allergol Immunopathol"},{"key":"10.1111\/all.13083-BIB0120|all13083-cit-0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1067\/mai.2003.1605","article-title":"Antithyroid antibodies in chronic urticaria and angioedema","volume":"112","author":"Kikuchi","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0121|all13083-cit-0121","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0021-8707(50)90017-7","article-title":"Passive transfer of cold urticaria","volume":"21","author":"Sherman","year":"1950","journal-title":"J Allergy"},{"key":"10.1111\/all.13083-BIB0122|all13083-cit-0122","first-page":"107","article-title":"Cold urticaria; report of a case: passive transfer and in vitro experiments with skin cells","volume":"35","author":"Samsoe-Jensen","year":"1955","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/all.13083-BIB0123|all13083-cit-0123","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9343(70)80110-3","article-title":"Cold urticaria. Immunologic studies","volume":"49","author":"Houser","year":"1970","journal-title":"Am J Med"},{"key":"10.1111\/all.13083-BIB0124|all13083-cit-0124","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1523-1747.ep12514352","article-title":"In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling","volume":"67","author":"Kaplan","year":"1976","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.13083-BIB0125|all13083-cit-0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1346-8138.1981.tb02580.x","article-title":"A case of cold urticaria due to a serum factor belonging to the IGE class","volume":"8","author":"Akiyama","year":"1981","journal-title":"J Dermatol"},{"key":"10.1111\/all.13083-BIB0126|all13083-cit-0126","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1056\/NEJM198110293051808","article-title":"Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies","volume":"305","author":"Kaplan","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1111\/all.13083-BIB0127|all13083-cit-0127","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaci.2006.04.003","article-title":"Successful treatment of cold-induced urticaria\/anaphylaxis with anti-IgE","volume":"117","author":"Boyce","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0128|all13083-cit-0128","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jaci.2014.02.005","article-title":"Accelerated dissociation of IgE-Fc\u03b5RI complexes by disruptive inhibitors actively desensitizes allergic effector cells","volume":"133","author":"Eggel","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0129|all13083-cit-0129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/all.12389","article-title":"Chronic urticaria and coagulation: pathophysiological and clinical aspects","volume":"69","author":"Tedeschi","year":"2014","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0130|all13083-cit-0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1398-9995.2007.01514.x","article-title":"Severe chronic urticaria is associated with elevated plasma levels of D-dimer","volume":"63","author":"Asero","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0131|all13083-cit-0131","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1398-9995.2009.02222.x","article-title":"Coagulation\/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria","volume":"65","author":"Takahagi","year":"2010","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0132|all13083-cit-0132","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2006.08.043","article-title":"Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria","volume":"119","author":"Asero","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0133|all13083-cit-0133","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaci.2005.12.1343","article-title":"Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum","volume":"117","author":"Asero","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0134|all13083-cit-0134","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1346-8138.2008.00474.x","article-title":"Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy","volume":"35","author":"Fujii","year":"2008","journal-title":"J Dermatol"},{"key":"10.1111\/all.13083-BIB0135|all13083-cit-0135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1398-9995.2010.02506.x","article-title":"Increase of coagulation potential in chronic spontaneous urticaria","volume":"66","author":"Takeda","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.13083-BIB0136|all13083-cit-0136","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2009.01.039","article-title":"Activation of the blood coagulation cascade is involved in patients with chronic urticaria","volume":"123","author":"Wang","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13083-BIB0137|all13083-cit-0137","first-page":"H1798","article-title":"Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms","volume":"264","author":"Schaeffer","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1111\/all.13083-BIB0138|all13083-cit-0138","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.133.6.3282","article-title":"Thrombin-induced degranulation of cultured bone marrow-derived mast cells","volume":"133","author":"Razin","year":"1984","journal-title":"J Immunol"},{"key":"10.1111\/all.13083-BIB0139|all13083-cit-0139","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000155748","article-title":"Expression of tissue factor by eosinophils in patients with chronic urticaria","volume":"148","author":"Cugno","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.13083-BIB0140|all13083-cit-0140","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1365-2222.2005.02380.x","article-title":"In chronic idiopathic urticaria autoantibodies against Fc\u03b5RII\/CD23 induce histamine release via eosinophil activation","volume":"35","author":"Puccetti","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13083-BIB0141|all13083-cit-0141","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WOX.0b013e3181bb965f","article-title":"Eosinophils in chronic urticaria: supporting or leading actors?","volume":"2","author":"Asero","year":"2009","journal-title":"World Allergy Organ J"},{"key":"10.1111\/all.13083-BIB0142|all13083-cit-0142","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(03)01752-7","article-title":"Activation of mast cells induced by agonists of proteinase-activated receptors under normal conditions and during acute inflammation in rats","volume":"471","author":"Dugina","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/all.13083-BIB0143|all13083-cit-0143","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1111\/all.13083-BIB0144|all13083-cit-0144","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaci.2010.08.012","article-title":"Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy","volume":"126","author":"Kaplan","year":"2010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.13083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/all.13083\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T12:46:54Z","timestamp":1749732414000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.13083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":144,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1111\/all.13083","archive":["Portico"],"relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,4]]}}}